Milestone Pharmaceuticals Inc (MIST)
1.74
-0.01
(-0.57%)
USD |
NASDAQ |
May 17, 16:00
1.74
0.00 (0.00%)
After-Hours: 20:00
Milestone Pharmaceuticals Enterprise Value: 53.84M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 53.84M |
| May 16, 2024 | 54.37M |
| May 15, 2024 | 53.30M |
| May 14, 2024 | 52.77M |
| May 13, 2024 | 51.71M |
| May 10, 2024 | 51.68M |
| May 09, 2024 | 51.68M |
| May 08, 2024 | 51.68M |
| May 07, 2024 | 53.81M |
| May 06, 2024 | 53.81M |
| May 03, 2024 | 51.15M |
| May 02, 2024 | 48.49M |
| May 01, 2024 | 46.36M |
| April 30, 2024 | 49.02M |
| April 29, 2024 | 44.76M |
| April 26, 2024 | 43.16M |
| April 25, 2024 | 45.29M |
| April 24, 2024 | 49.55M |
| April 23, 2024 | 51.68M |
| April 22, 2024 | 47.95M |
| April 19, 2024 | 48.49M |
| April 18, 2024 | 47.95M |
| April 17, 2024 | 54.34M |
| April 16, 2024 | 54.87M |
| April 15, 2024 | 54.61M |
| Date | Value |
|---|---|
| April 12, 2024 | 53.28M |
| April 11, 2024 | 51.41M |
| April 10, 2024 | 50.08M |
| April 09, 2024 | 50.08M |
| April 08, 2024 | 58.07M |
| April 05, 2024 | 57.00M |
| April 04, 2024 | 54.34M |
| April 03, 2024 | 54.87M |
| April 02, 2024 | 57.00M |
| April 01, 2024 | 58.60M |
| March 28, 2024 | 78.91M |
| March 27, 2024 | 79.44M |
| March 26, 2024 | 79.97M |
| March 25, 2024 | 75.72M |
| March 22, 2024 | 76.25M |
| March 21, 2024 | 66.68M |
| March 20, 2024 | 63.49M |
| March 19, 2024 | 60.84M |
| March 18, 2024 | 62.96M |
| March 15, 2024 | 60.84M |
| March 14, 2024 | 59.24M |
| March 13, 2024 | 60.84M |
| March 12, 2024 | 62.70M |
| March 11, 2024 | 65.62M |
| March 08, 2024 | 64.03M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-78.07M
Minimum
Mar 24 2020
593.65M
Maximum
Jun 28 2019
111.74M
Average
70.21M
Median
Enterprise Value Benchmarks
| Acasti Pharma Inc | 0.1704M |
| Aurinia Pharmaceuticals Inc | 473.30M |
| Edesa Biotech Inc | 11.83M |
| Lexaria Bioscience Corp | 35.42M |
| Xenon Pharmaceuticals Inc | 2.304B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -10.35M |
| Total Expenses (Quarterly) | 10.48M |
| EPS Diluted (Quarterly) | -0.21 |
| Earnings Yield | -71.84% |
| Normalized Earnings Yield | -79.89 |